Thermo Fisher Scientific Inc. $TMO Stock Position Trimmed by James Hambro & Partners LLP

robot
Abstract generation in progress

James Hambro & Partners LLP reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 3.4% in the fourth quarter, now holding 241,339 shares valued at $139.9 million. Despite this trim, TMO remains the firm’s 7th largest position, comprising approximately 5.0% of its portfolio. Analysts maintain a “Moderate Buy” consensus rating with an average target price of $632.50, and the company recently raised its quarterly dividend to $0.47 per share.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin